+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Antimicrobial Therapeutics Reviews. Antibiotics that Target the Ribosome, Volume 1241. Annals of the New York Academy of Sciences

  • ID: 2178965
  • Book
  • June 2012
  • Region: United States
  • 179 Pages
  • John Wiley and Sons Ltd
1 of 2
This second installment of
Antimicrobial Therapeutics Reviews presents scholarly reviews on several key areas in the field of antimicrobial therapeutics, including several papers on issues relating to antibiotics that target the ribosome.  Topics covered include plasmid–encoded resistance determinants for agents that bind the ribosome, new compound classes targeting the ribosome, sequence–specific action of antibiotics binding the ribosome, smFRET approaches to determine MOA of antibiotics binding to the ribosome, new approaches for treating Staphylococcus biofilm infections, and the history of tetracyclins.  The volume also features reviews dealing with drug development, such as pleuromutilin discovery and development challenges and an update on newer oxazolidinones such as torezolid and radezolid, and a review on regulatory hurdles for new antibiotics.

NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit Annals online and discounts on print volumes. Please visit <a href="[external URL] for more information about becoming a member.
Note: Product cover images may vary from those shown
2 of 2
Karen Bush
Note: Product cover images may vary from those shown